
TIBET AIM PHARM. INC. — Investor Relations & Filings
Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 重大信息内部保密制度 | 2026-04-07 | Chinese | |
| 重大信息内部报告制度 | 2026-04-07 | Chinese | |
| 会计师事务所选聘制度 | 2026-04-07 | Chinese | |
| 董事会提名委员会工作细则 | 2026-04-07 | Chinese | |
| 关于向2026年限制性股票激励计划激励对象首次授予限制性股票的公告 | 2026-03-11 | Chinese | |
| 第四届董事会第四次会议决议公告 | 2026-03-11 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38419014 | 重大信息内部保密制度 | 2026-04-07 | Chinese | ||
| 38419012 | 重大信息内部报告制度 | 2026-04-07 | Chinese | ||
| 38419009 | 会计师事务所选聘制度 | 2026-04-07 | Chinese | ||
| 38419008 | 董事会提名委员会工作细则 | 2026-04-07 | Chinese | ||
| 38419004 | 关于向2026年限制性股票激励计划激励对象首次授予限制性股票的公告 | 2026-03-11 | Chinese | ||
| 38418996 | 第四届董事会第四次会议决议公告 | 2026-03-11 | Chinese | ||
| 38418993 | 董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单(授予日)的核查意见 | 2026-03-11 | Chinese | ||
| 38418984 | 北京植德律师事务所关于西藏易明西雅医药科技股份有限公司2026年限制性股票激励计划首次授予事项的法律意见书 | 2026-03-11 | Chinese | ||
| 38418972 | 北京植德律师事务所关于西藏易明西雅医药科技股份有限公司2026年第一次临时股东会的法律意见书 | 2026-03-10 | Chinese | ||
| 38418971 | 关于公司2026年限制性股票激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告 | 2026-03-10 | Chinese | ||
| 38418968 | 2026年第一次临时股东会决议公告 | 2026-03-10 | Chinese | ||
| 38418960 | 董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的审核意见及公示情况说明 | 2026-03-03 | Chinese | ||
| 38418956 | 关于增加投资者热线电话的公告 | 2026-03-03 | Chinese | ||
| 38418952 | 董事会薪酬与考核委员会关于公司 2026 年限制性股票激励计划相关事项的核查意见 | 2026-02-11 | Chinese | ||
| 38418949 | 2026年限制性股票激励计划实施考核管理办法 | 2026-02-11 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIBET AIM PHARM. INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54828/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54828 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54828 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54828 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54828}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIBET AIM PHARM. INC. (id: 54828)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.